{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:47:12Z","timestamp":1794667632764,"version":"4.9.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:00:00Z","timestamp":1794096000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["Z1A HD009001"],"award-info":[{"award-number":["Z1A HD009001"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00 HD099520"],"award-info":[{"award-number":["R00 HD099520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymgme.2025.109287","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:42:18Z","timestamp":1762209738000},"page":"109287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["MEHMO syndrome: Review and proposed classification as an eIF2-related neuroendocrinopathy"],"prefix":"10.1016","volume":"146","author":[{"given":"An N.","family":"Dang Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Navid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Young-Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4\u20135","key":"10.1016\/j.ymgme.2025.109287_bb0005","first-page":"353","article-title":"Microencephalic nanism, severe retardation, hypertonia, obesity, and hypogonadism in two brothers: a new syndrome?","volume":"37","author":"Delozier-Blanchet","year":"1989","journal-title":"J. Genet. Hum."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.ejhg.5200180","article-title":"MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel syndrome: assignment of disease locus to xp21.1-p22.13","volume":"6","author":"Steinmuller","year":"1998","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molcel.2012.09.005","article-title":"eIF2gamma mutation that disrupts eIF2 complex integrity links intellectual disability to impaired translation initiation","volume":"48","author":"Borck","year":"2012","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109287_bb0020","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/ajmg.a.37792","article-title":"Two novel EIF2S3 mutations associated with syndromic intellectual disability with severe microcephaly, growth retardation, and epilepsy","volume":"170","author":"Moortgat","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/humu.23170","article-title":"EIF2S3 mutations associated with severe X-linked intellectual disability syndrome MEHMO","volume":"38","author":"Skopkova","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109287_bb0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ebiom.2019.03.013","article-title":"Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation","volume":"42","author":"Gregory","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.molcel.2019.11.008","article-title":"Suppression of MEHMO syndrome mutation in eIF2 by small molecule ISRIB","volume":"77","author":"Young-Baird","year":"2020","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41525-022-00344-7","article-title":"A robust pipeline for ranking carrier frequencies of autosomal recessive and X-linked Mendelian disorders","volume":"7","author":"Zhu","year":"2022","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.ymgme.2025.109287_bb0045","author":"United States Census Bureau"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0050","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1016\/S0021-9258(17)41878-3","article-title":"Translation initiation factor eIF-2. Cloning and expression of the human cDNA encoding the gamma-subunit","volume":"269","author":"Gaspar","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.ymgme.2025.109287_bb0055","doi-asserted-by":"crossref","first-page":"E1344","DOI":"10.1073\/pnas.1400129111","article-title":"Protein phosphatase PP1\/GLC7 interaction domain in yeast eIF2gamma bypasses targeting subunit requirement for eIF2alpha dephosphorylation","volume":"111","author":"Rojas","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109287_bb0060","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/hmg\/7.11.1725","article-title":"Characterization of genes encoding translation initiation factor eIF-2gamma in mouse and human: sex chromosome localization, escape from X-inactivation and evolution","volume":"7","author":"Ehrmann","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2025.109287_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590408","article-title":"Does EIF2S3 Retrogene activation regulate Cancer\/testis antigen expression in human cancers?","volume":"10","author":"Rohozinski","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0070","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41431-018-0291-3","article-title":"Skewed X-inactivation is common in the general female population","volume":"27","author":"Shvetsova","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109287_bb0075","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/molbev\/mst148","article-title":"Genes that escape X-inactivation in humans have high intraspecific variability in expression, are associated with mental impairment but are not slow evolving","volume":"30","author":"Zhang","year":"2013","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13059-015-0667-4","article-title":"Sex chromosome-to-autosome transposition events counter Y-chromosome gene loss in mammals","volume":"16","author":"Hughes","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymgme.2025.109287_bb0085","author":"The Human Protein Atlas"},{"issue":"6220","key":"10.1016\/j.ymgme.2025.109287_bb0090","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ymgme.2025.109287_bb0095","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.str.2015.06.014","article-title":"Cdc123, a cell cycle regulator needed for eIF2 assembly, is an ATP-grasp protein with unique features","volume":"23","author":"Panvert","year":"2015","journal-title":"Structure"},{"issue":"30","key":"10.1016\/j.ymgme.2025.109287_bb0100","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M113.472290","article-title":"Translation initiation requires cell division cycle 123 (Cdc123) to facilitate biogenesis of the eukaryotic initiation factor 2 (eIF2)","volume":"288","author":"Perzlmaier","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41594-023-01196-0","article-title":"The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A","volume":"31","author":"Querido","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ymgme.2025.109287_bb0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev-biochem-060713-035802","article-title":"The scanning mechanism of eukaryotic translation initiation","volume":"83","author":"Hinnebusch","year":"2014","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cge.13831","article-title":"Novel pathogenic EIF2S3 missense variants causing clinically variable MEHMO syndrome with impaired eIF2gamma translational function, and literature review","volume":"98","author":"Kotzaeridou","year":"2020","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jmb.2003.11.025","article-title":"GTP-dependent recognition of the methionine moiety on initiator tRNA by translation factor eIF2","volume":"335","author":"Kapp","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109287_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1491","article-title":"Regulation of translation initiation factor eIF2B at the hub of the integrated stress response","volume":"9","author":"Pavitt","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"6439","key":"10.1016\/j.ymgme.2025.109287_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1126\/science.aaw4104","article-title":"Structural basis for eIF2B inhibition in integrated stress response","volume":"364","author":"Kashiwagi","year":"2019","journal-title":"Science"},{"issue":"6439","key":"10.1016\/j.ymgme.2025.109287_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.aaw2922","article-title":"eIF2B-catalyzed nucleotide exchange and phosphoregulation by the integrated stress response","volume":"364","author":"Kenner","year":"2019","journal-title":"Science"},{"issue":"6489","key":"10.1016\/j.ymgme.2025.109287_bb0140","doi-asserted-by":"crossref","first-page":"eaat5314","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: from mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3945\/an.112.002113","article-title":"Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism","volume":"3","author":"Baird","year":"2012","journal-title":"Adv. Nutr."},{"issue":"33","key":"10.1016\/j.ymgme.2025.109287_bb0150","doi-asserted-by":"crossref","first-page":"16927","DOI":"10.1074\/jbc.R116.733899","article-title":"Upstream open Reading frames differentially regulate gene-specific translation in the integrated stress response","volume":"291","author":"Young","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"11\u221212","key":"10.1016\/j.ymgme.2025.109287_bb0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1101\/gad.350752.123","article-title":"Translational regulation by uORFs and start codon selection stringency","volume":"37","author":"Dever","year":"2023","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0160","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0165","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1083\/jcb.153.5.1011","article-title":"Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha","volume":"153","author":"Novoa","year":"2001","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0170","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1083\/jcb.200308075","article-title":"Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells","volume":"163","author":"Jousse","year":"2003","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109287_bb0175","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1101\/gad.12.7.982","article-title":"CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum","volume":"12","author":"Zinszner","year":"1998","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109287_bb0180","doi-asserted-by":"crossref","first-page":"msae177","DOI":"10.1093\/molbev\/msae177","article-title":"Insertions and deletions: computational methods, evolutionary dynamics, and biological applications","volume":"41","author":"Redelings","year":"2024","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ymgme.2025.109287_bb0185","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109287_bb0190","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/nar\/gky1213","article-title":"MEHMO syndrome mutation EIF2S3-I259M impairs initiator met-tRNAiMet binding to eukaryotic translation initiation factor eIF2","volume":"47","author":"Young-Baird","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0195","article-title":"Binding of human Cdc123 to eIF2\u03b3","volume":"215","author":"Peralta","year":"2023","journal-title":"J. Struct. Biol."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109287_bb0200","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/humu.24215","article-title":"Broadening the phenotypic spectrum and physiological insights related to EIF2S3 variants","volume":"42","author":"Moortgat","year":"2021","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109287_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104421","article-title":"mRNA analysis revealed a novel pathogenic EIF2S3 variant causing MEHMO syndrome","volume":"65","author":"Ivanova","year":"2022","journal-title":"Eur. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0210","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.367","article-title":"A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation","volume":"41","author":"Tarpey","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2025.109287_bb0215","series-title":"Hyperinsulinaemic Hypoglycemia as MEHMO Syndrome Component: A Case Report","author":"Gubaeva","year":"2021"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109287_bb0220","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.braindev.2021.02.002","article-title":"Ketogenic diet for refractory epilepsy with MEHMO syndrome: caution for acute necrotizing pancreatitis","volume":"43","author":"Mori","year":"2021","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0225","article-title":"MEHMO syndrome caused by EIF2S3 gene mutation: a report of two cases and literature review","volume":"39","author":"Liu","year":"2021","journal-title":"J. Clin. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2025.109287_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5989","article-title":"Expanding the phenotype of the recurrent truncating eIF2gamma pathogenic variant p.(Ile465Serfs*4) identified in two brothers with MEHMO syndrome","volume":"10","author":"Ygberg","year":"2022","journal-title":"Clin. Case Reports"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109287_bb0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.33549\/physiolres.933689","article-title":"Neonatal hypoglycemia, early-onset diabetes and hypopituitarism due to the mutation in EIF2S3 gene causing MEHMO syndrome","volume":"67","author":"Stanik","year":"2018","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ymgme.2025.109287_bb0240","author":"Orphanet"},{"key":"10.1016\/j.ymgme.2025.109287_bb0245","author":"Genetic Testing Registry"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0250","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s12035-022-03139-0","article-title":"Endoplasmic reticulum stress-regulated chaperones as a serum biomarker panel for Parkinson\u2019s disease","volume":"60","author":"Mnich","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109287_bb0255","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1021\/acs.jmedchem.3c02422","article-title":"Discovery of DNL343: a potent, selective, and brain-penetrant eIF2B activator designed for the treatment of neurodegenerative diseases","volume":"67","author":"Craig","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymgme.2025.109287_bb0260","doi-asserted-by":"crossref","first-page":"RP92173","DOI":"10.7554\/eLife.92173","article-title":"DNL343 is an investigational CNS penetrant eukaryotic initiation factor 2B activator that prevents and reverses the effects of neurodegeneration caused by the integrated stress response","volume":"12","author":"Yulyaningsih","year":"2024","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.ymgme.2025.109287_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14600","article-title":"GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system","volume":"30","author":"Asundi","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymgme.2025.109287_bb0270","author":"Salguero"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109287_bb0275","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41574-021-00539-5","article-title":"Advances in differential diagnosis and management of growth hormone deficiency in children","volume":"17","author":"Hage","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0280","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0285","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/brainsci11050581","article-title":"Molecular genetics of microcephaly primary hereditary: an overview","volume":"11","author":"Siskos","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ymgme.2025.109287_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110658","article-title":"The roles of ER stress in epilepsy: molecular mechanisms and therapeutic implications","volume":"131","author":"Fu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109287_bb0295","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s11064-019-02870-w","article-title":"Sodium valproate reduces neuronal apoptosis in acute Pentylenetetrzole-induced seizures via inhibiting ER stress","volume":"44","author":"Fu","year":"2019","journal-title":"Neurochem. Res."},{"issue":"5711","key":"10.1016\/j.ymgme.2025.109287_bb0300","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1126\/science.1101902","article-title":"A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress","volume":"307","author":"Boyce","year":"2005","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109287_bb0305","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00702-014-1208-0","article-title":"Salubrinal, ER stress inhibitor, attenuates kainic acid-induced hippocampal cell death","volume":"121","author":"Kim","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109287_bb0310","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11064-016-1835-y","article-title":"Mdivi-1 protects epileptic hippocampal neurons from apoptosis via inhibiting oxidative stress and endoplasmic reticulum stress in vitro","volume":"41","author":"Xie","year":"2016","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109287_bb0315","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.molmet.2017.06.001","article-title":"Endoplasmic reticulum stress and eIF2alpha phosphorylation: the Achilles heel of pancreatic beta cells","volume":"6","author":"Cnop","year":"2017","journal-title":"Mol. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109287_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101797","article-title":"Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression","volume":"9","author":"Cadavez","year":"2014","journal-title":"PLoS One"},{"issue":"5790","key":"10.1016\/j.ymgme.2025.109287_bb0325","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ymgme.2025.109287_bb0330","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.2337\/db09-0685","article-title":"Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB","volume":"58","author":"Cunha","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","article-title":"GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress","volume":"4","author":"Yusta","year":"2006","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109287_bb0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.2040-1124.2010.00075.x","article-title":"GLP-1 receptor agonist attenuates endoplasmic reticulum stress-mediated beta-cell damage in Akita mice","volume":"2","author":"Yamane","year":"2011","journal-title":"J. Diabetes Investig."},{"issue":"43","key":"10.1016\/j.ymgme.2025.109287_bb0345","doi-asserted-by":"crossref","first-page":"22524","DOI":"10.1074\/jbc.M116.741694","article-title":"Peroxisome proliferator-activated receptor-gamma activation augments the beta-cell unfolded protein response and rescues early glycemic deterioration and beta cell death in non-obese diabetic mice","volume":"291","author":"Maganti","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109287_bb0350","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00498","article-title":"Pharmacological brake-release of mRNA translation enhances cognitive memory","volume":"2","author":"Sidrauski","year":"2013","journal-title":"Elife"},{"issue":"6383","key":"10.1016\/j.ymgme.2025.109287_bb0355","doi-asserted-by":"crossref","first-page":"eaaq0939","DOI":"10.1126\/science.aaq0939","article-title":"Structure of the nucleotide exchange factor eIF2B reveals mechanism of memory-enhancing molecule","volume":"359","author":"Tsai","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0360","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molcel.2020.10.031","article-title":"ISRIB blunts the integrated stress response by allosterically Antagonising the inhibitory effect of phosphorylated eIF2 on eIF2B","volume":"81","author":"Zyryanova","year":"2021","journal-title":"Mol. Cell"},{"issue":"668","key":"10.1016\/j.ymgme.2025.109287_bb0365","doi-asserted-by":"crossref","first-page":"eabc5429","DOI":"10.1126\/scisignal.abc5429","article-title":"Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer\u2019s disease","volume":"14","author":"Oliveira","year":"2021","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0370","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0025-17.2017","article-title":"Role of endoplasmic reticulum stress in learning and memory impairment and Alzheimer\u2019s disease-like neuropathology in the PS19 and APP(Swe) mouse models of Tauopathy and amyloidosis","volume":"4","author":"Briggs","year":"2017","journal-title":"eNeuro"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0375","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41398-022-01862-9","article-title":"Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer\u2019s disease","volume":"12","author":"Hu","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.ymgme.2025.109287_bb0380","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41419-020-2601-2","article-title":"Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis","volume":"11","author":"Bugallo","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6467","key":"10.1016\/j.ymgme.2025.109287_bb0385","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.aaw5185","article-title":"Activation of the ISR mediates the behavioral and neurophysiological abnormalities in down syndrome","volume":"366","author":"Zhu","year":"2019","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.ymgme.2025.109287_bb0390","doi-asserted-by":"crossref","first-page":"E6420","DOI":"10.1073\/pnas.1707661114","article-title":"Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury","volume":"114","author":"Chou","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.ymgme.2025.109287_bb0395","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/acn3.50826","article-title":"Vanishing white matter: deregulated integrated stress response as therapy target","volume":"6","author":"Abbink","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymgme.2025.109287_bb0400","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42940","article-title":"eIF2B activator prevents neurological defects caused by a chronic integrated stress response","volume":"8","author":"Wong","year":"2019","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0405","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3390\/ijms23042021","article-title":"Targeting the unfolded protein response as a disease-modifying pathway in dementia","volume":"23","author":"Sidhom","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.ymgme.2025.109287_bb0410","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.3390\/ijms242417321","article-title":"The PPP1R15 family of eIF2-alpha phosphatase targeting subunits (GADD34 and CReP)","volume":"24","author":"Hicks","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ymgme.2025.109287_bb0415","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/brain\/awab167","article-title":"The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial","volume":"144","author":"Dalla Bella","year":"2021","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0420","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/0929867328666210526144654","article-title":"Enzyme replacement therapy for genetic disorders associated with enzyme deficiency","volume":"29","author":"Marchetti","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109287_bb0425","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1016\/j.ymthe.2023.11.001","article-title":"The state of cell and gene therapy in 2023","volume":"31","author":"Chancellor","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0430","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-024-01070-1","article-title":"Gene therapy for ultrarare diseases: a geneticist\u2019s perspective","volume":"31","author":"Hwu","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0435","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","article-title":"Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun. Med. (Lond)"},{"issue":"10","key":"10.1016\/j.ymgme.2025.109287_bb0440","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/cells13100800","article-title":"CRISPR-based gene therapies: from preclinical to clinical treatments","volume":"13","author":"Laurent","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0445","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1038\/s41467-023-41799-1","article-title":"Secondary structures that regulate mRNA translation provide insights for ASO-mediated modulation of cardiac hypertrophy","volume":"14","author":"Hedaya","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0450","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ymthe.2024.02.004","article-title":"Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice","volume":"32","author":"Clarke","year":"2024","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109287_bb0455","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.ymthe.2025.06.012","article-title":"In utero genetic therapy: treatment of early onset neurological disorders before they start","volume":"33","author":"Borges","year":"2025","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0460","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajhg.2020.02.016","article-title":"De novo EIF2AK1 and EIF2AK2 variants are associated with developmental delay, leukoencephalopathy, and neurologic decompensation","volume":"106","author":"Mao","year":"2020","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109287_bb0465","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.25973","article-title":"EIF2AK2 missense variants associated with early onset generalized dystonia","volume":"89","author":"Kuipers","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2025.109287_bb0470","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X231176673","article-title":"A recurrent De novo variant in EIF2AK2 causes a Hypomyelinating Leukodystrophy","volume":"10","author":"Macintosh","year":"2023","journal-title":"Child Neurol. Open"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109287_bb0475","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-024-03434-8","article-title":"Dysregulated RNA editing of EIF2AK2 in polycystic ovary syndrome: clinical relevance and functional implications","volume":"22","author":"Kong","year":"2024","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109287_bb0480","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome","volume":"25","author":"Delepine","year":"2000","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109287_bb0485","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.2337\/db15-0477","article-title":"A missense mutation in PPP1R15B causes a syndrome including diabetes, short stature, and microcephaly","volume":"64","author":"Abdulkarim","year":"2015","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.ymgme.2025.109287_bb0490","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1093\/hmg\/ddv337","article-title":"Homozygous mutation in the eukaryotic translation initiation factor 2alpha phosphatase gene, PPP1R15B, is associated with severe microcephaly, short stature and intellectual disability","volume":"24","author":"Kernohan","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109287_bb0495","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"issue":"10028","key":"10.1016\/j.ymgme.2025.109287_bb0500","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ymgme.2025.109287_bb0505","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajhg.2024.07.019","article-title":"Implementation of a dyadic nomenclature for monogenic diseases","volume":"111","author":"Thaxton","year":"2024","journal-title":"Am. J. Hum. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:48:13Z","timestamp":1773877693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1096719225002793"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109287","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEHMO syndrome: Review and proposed classification as an eIF2-related neuroendocrinopathy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109287"}}